Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

DR5-targeted antibody-drug conjugate

DRUG CLASS:

DR5-targeted antibody-drug conjugate

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

TNFRSF10B overexpression

Pancreatic Cancer

Sensitive: D – Preclinical

Sensitive: D – Preclinical